Research Article

Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study

Figure 1

Kaplan-Meier cumulative probability of major bleeding event-free survival in recipients of dabigatran (DAB) and vitamin K antagonist (VKA) treatment.